Sudeep Pharma IPO
Sudeep Pharma IPO
Overview
Sudeep Pharma IPO is a book build issue of ₹895.00 crores. The issue is a combination of fresh issue of 0.16 crore shares aggregating to ₹95.00 crores and offer for sale of 1.35 crore shares aggregating to ₹800.00 crores. Sudeep Pharma IPO bidding opened for subscription on Nov 21, 2025 and will close on Nov 25, 2025. The allotment for the Sudeep Pharma IPO is expected to be finalized on Nov 26, 2025. Sudeep Pharma IPO will list on BSE, NSE with a tentative listing date fixed as Nov 28, 2025. Sudeep Pharma IPO price band is set at ₹563.00 to ₹593.00 per share . The lot size for an application is 25. The minimum amount of investment required by an retail is ₹14,825 (25 shares) (based on upper price). The lot size investment for sNII is 14 lots (350 shares), amounting to ₹2,07,550, and for bNII, it is 68 lots (1,700 shares), amounting to ₹10,08,100.
Total Shares
1,50,92,750
Issue Size
₹895.00 Cr
Price Band
₹563 – ₹593
Lot Size
25 shares
Min. Investment
₹14,825
Max. Investment
₹1,92,725
Open Date
21 Nov, 2025
Close Date
25 Nov, 2025
Allotment
26 Nov, 2025
Listing
28 Nov, 2025
Max. Investment
₹1,92,725
Announced
21 Nov, 2025
Opening Date
21 Nov, 2025
Closing Date
25 Nov, 2025
Basis of Allotment
26 Nov, 2025
Initiation of Refunds
27 Nov, 2025
Credit of Shares
27 Nov, 2025
Listing Date
28 Nov, 2025
Live GMP
Est. Listing: ₹683
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Sudeep Pharma IPO
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium
The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors</
Sudeep Pharma IPO Share Price
Issue Breakdown
Shareholding
Dilution: 1.4% increase in shares
Sudeep Pharma IPO Promoters Holding
Sudeep Pharma IPO Financial Health
Sudeep Pharma Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
Sudeep Pharma IPO Lot Size
Investors can bid for a minimum of 25 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 25 | ₹14,825 |
| Retail (Max) | 13 | 325 | ₹1,92,725 |
| S-HNI (Min) | 14 | 350 | ₹2,07,550 |
| S-HNI (Max) | 67 | 1675 | ₹9,93,275 |
| B-HNI (Min) | 68 | 1700 | ₹10,08,100 |
(All values in CR)
Sudeep Pharma IPO Valuations
KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| Debt/Equity | 0.20 |
| RoNW | 27.88 |
| PAT Margin | 27.63 |
| EBITDA Margin | 39.70 |
| Price to Book Value | 12.93 |
| Market Capitalization | 6,697.85 |
(All values in CR)
Sudeep Pharma IPO Strength & Risk
Sudeep Pharma IPO Strength:
- Established manufacturer of mineral-based excipients and specialty ingredients for pharma, food and nutrition sectors.
- Wide and diversified product portfolio catering to multiple high-value applications.
- Strong R&D capabilities supporting innovation and product customisation.
- Long-standing relationships with multinational and global clients.
- Compliance with major quality standards, enhancing reliability and export readiness.
- Presence across international markets, supporting diversified revenue sources.
Sudeep Pharma IPO Risk:
- High dependence on a few major customers, increasing revenue concentration risk.
- Significant exposure to export markets, making the business vulnerable to regulatory and currency changes.
- Sensitivity to raw-material price fluctuations and supply-chain disruptions.
- Possible operational risks due to manufacturing concentration in specific regions.
- Competitive pressures from domestic and global ingredient manufacturers.
- Large offer-for-sale component may raise concerns about existing shareholders reducing stake.
Sudeep Pharma IPO Subscriptions Status
Sudeep Pharma IPO subscribed 93.71 times. The public issue subscribed 15.65 times in the retail category, 213.08 times in QIB (Ex Anchor), and 116.72 times in the NII category by November 25, 2025 5:19:33 PM (Day 3).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 45,27,823 | 45,27,823 | 268.5 |
| QIB (Ex Anchor) | 213.08 | 30,18,553 | 64,31,88,450 | 38 |
| Non-Institutional Buyers | 116.72 | 22,63,912 | 26,42,36,925 | 15 |
| bNII (bids above ₹10L) | 134.91 | 15,09,275 | 20,36,19,700 | 12 |
| sNII (bids below ₹10L) | 80.33 | 7,54,637 | 6,06,17,225 | 3 |
| Retail | 15.65 | 52,82,462 | 8,26,61,200 | 4 |
| Total | 93.71 | 1,05,64,927 | 99,00,86,575 | 58 |
Sudeep Pharma IPO GMP
Sudeep Pharma IPO last GMP is ₹90, last updated Nov 25th 2025 04:37 PM. With the price band of 593.00, Sudeep Pharma IPO's estimated listing price is ₹683 (cap price + today's GMP).The expected percentage gain/loss per share is 15.18%. >> Sudeep Pharma IPO Retail Subject to Sauda: ₹1700 >> Sudeep Pharma IPO Small HNI Subject to Sauda: ₹23800 The lowest GMP is ₹0.00, while the highest GMP is ₹130.00.
Last updated 25 Nov, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 25 Nov, 2025 | 593 | ₹90 | 1700/23800 | ₹683 (15.18%) | 2250 | 25 Nov, 2025 |
| 24 Nov, 2025 | 593 | ₹90▼ | 1700/23800 | ₹683 (15.18%) | 2250 | 24 Nov, 2025 |
| 23 Nov, 2025 | 593 | ₹121▲ | 2300/32200 | ₹714 (20.40%) | 3025 | 23 Nov, 2025 |
| 22 Nov, 2025 | 593 | ₹113▼ | 2100/29400 | ₹706 (19.06%) | 2825 | 22 Nov, 2025 |
| 21 Nov, 2025 | 593 | ₹115▼ | 2200/30800 | ₹708 (19.39%) | 2875 | 21 Nov, 2025 |
| 20 Nov, 2025 | 593 | ₹122▼ | 2300/32200 | ₹715 (20.57%) | 3050 | 20 Nov, 2025 |
| 19 Nov, 2025 | 593 | ₹130▲ | 2500/35000 | ₹723 (21.92%) | 3250 | 19 Nov, 2025 |
| 18 Nov, 2025 | 593 | ₹93▲ | 1800/25200 | ₹686 (15.68%) | 2325 | 18 Nov, 2025 |
| 17 Nov, 2025 | 0 | ₹0 | - | ₹ (%) | - | 17 Nov, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Sudeep Pharma IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Sudeep Pharma IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.